These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 2915557

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K, Otani H, Yamamura T, Nakao Y, Hattori R, Ninomiya H, Osako M, Imamura H.
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart.
    Kempsford RD, Hearse DJ.
    J Thorac Cardiovasc Surg; 1989 Jun; 97(6):856-63. PubMed ID: 2498580
    [Abstract] [Full Text] [Related]

  • 7. Protection of the immature heart. Temperature-dependent beneficial or detrimental effects of multidose crystalloid cardioplegia in the neonatal rabbit heart.
    Kempsford RD, Hearse DJ.
    J Thorac Cardiovasc Surg; 1990 Feb; 99(2):269-79. PubMed ID: 2299864
    [Abstract] [Full Text] [Related]

  • 8. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R, Chambers DJ.
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution.
    Yang SS, Hearse DJ.
    Can J Cardiol; 1989 Nov; 5(8):401-7. PubMed ID: 2514036
    [Abstract] [Full Text] [Related]

  • 16. Species differences in susceptibility to ischemic injury and responsiveness to myocardial protection.
    Galiñanes M, Hearse DJ.
    Cardioscience; 1990 Jun; 1(2):127-43. PubMed ID: 2102801
    [Abstract] [Full Text] [Related]

  • 17. Optimal myocardial protection during crystalloid cardioplegia. Interrelationship between volume and duration of infusion.
    Takahashi A, Chambers DJ, Braimbridge MV, Hearse DJ.
    J Thorac Cardiovasc Surg; 1988 Nov; 96(5):730-40. PubMed ID: 3184967
    [Abstract] [Full Text] [Related]

  • 18. Improved myocardial protection by oxygenation of St. Thomas' Hospital cardioplegic solutions. Studies in the rat.
    Ledingham SJ, Braimbridge MV, Hearse DJ.
    J Thorac Cardiovasc Surg; 1988 Jan; 95(1):103-11. PubMed ID: 3336223
    [Abstract] [Full Text] [Related]

  • 19. The immature and the mature myocardium. Responses to multidose crystalloid cardioplegia.
    Magovern JA, Pae WE, Miller CA, Waldhausen JA.
    J Thorac Cardiovasc Surg; 1988 Apr; 95(4):618-24. PubMed ID: 3352295
    [Abstract] [Full Text] [Related]

  • 20. Protection of the chronic hypoxic immature rat heart during global ischemia.
    Karck M, Ziemer G, Zoeller M, Schulte S, Juergens KD, Weisser H, Haverich A.
    Ann Thorac Surg; 1995 Mar; 59(3):699-706. PubMed ID: 7887715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.